PCV13 vaccine may have big effect among young children

03/12/2010 | HealthDay News

A CDC report said a recently approved broader pneumococcal vaccine could significantly reduce the rate of disease in young children. The FDA approved the PCV13 vaccine last month, and it covers pneumococcal strains that were responsible for 64% of pneumococcal cases in children under age 5 in 2007.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ